Table I.
Study | Year | Country | Tinnitus Population Studied | Instrument | Patients with Tinnitus, n | Men, % | Mean Age or Range, y | Depression Prevalence, % | Quality Score |
---|---|---|---|---|---|---|---|---|---|
Adoga7 | 2008 | Nigeria | All tinnitus patients who presented to ENT clinic. | HADS | 92 | 45.7 | 36.0 | 17.4 | 4 |
Andersson14 | 2009 | Sweden | Cochlear implant recipients who reported tinnitus | HADS | 107 | 38.7 | 54.4 | 5.6 | 3 |
Barros Suzuki15 | 2016 | Brazil | Patients with tinnitus complaints for > 1 y without improvement with drug therapies and no tinnitus treatment for at least 3 mo | HADS | 10 | 50 | 41–78 | 10.0 | 3 |
Bartels16 | 2008 | Netherlands | Consecutive patients with chronic tinnitus seen at ENT clinic | HADS ≥8 | 265 | 69.8 | 55.4 | 49.1 | 4 |
Belli8 | 2008 | Turkey | Patients with tinnitus symptoms for at least 1 mo with no drug therapies for 3 mo prior to the study | SCI for DSM-III | 85 | 45.6 | 38.4 | 5.6 | 4 |
Carlsson17 | 2015 | Sweden | Patients with severe to profound hearing impairment who reported tinnitus | HADS ≥8 | 704 | 51 | 68.0 | 24.6 | 3 |
Crocetti18 | 2009 | Italy | Patients with idiopathic tinnitus for at least 6 mo (exclusion criteria: Meniere’s disease and chronic pain) | BDI | 108 | 66.7 | 48.0 | 13.0 | 4 |
Das19 | 2012 | USA | Patients with nonpulsatile tinnitus of at least 6 mo (exclusion criteria: active diagnosis of any acute or chronic brain-related neurologic condition) | PHQ-9 ≥6 | 37 | 54 | 50.0 | 24.3 | 2 |
Fernandes20 | 2013 | Brazil | Patients with orofacial pain and self-reported tinnitus | RDC/TMD | 129 | 17.9 | 37.7 | 68.2 | 3 |
Folmer21 | 2008 | USA | Consecutive patients with chronic tinnitus presenting to ENT clinic for initial appointment | aBDI | 196 | 68.4 | 52.1 | 49.0 | 4 |
Gomaa22 | 2014 | Egypt | Patients with subjective tinnitus associated with hearing loss presenting to ENT clinic | DASS | 100 | 40 | 20–60 | 84 | 4 |
Granjeiro23 | 2013 | Brazil | Patients with tinnitus and normal hearing (exclusion criteria: drug treatment for tinnitus in past 6 mo; tinnitus <6 mo; history of acoustic trauma, vascular disease, ear surgery, vestibular disorders, head trauma, and neurologic diseases; recent intake of ototoxic drugs and chemo-/radiotherapy). | BDI | 68 | 45.6 | 36.8 | 66.2 | 3 |
Hilgenberg24 | 2012 | Brazil | Patients with tinnitus receiving regular dental care (exclusion criteria: Ménière’s disease, history of noise exposure or ear surgery or infections; frequent use of headphones; abuse of ototoxic medication or substances, including fluoxetine and alcohol; and systemic diseases [eg, diabetes, hypertension] beyond control) | RDC/TMD | 100 | 16 | 39.2 | 70.0 | 3 |
Jacques25 | 2013 | Belgium | Patients with chronic tinnitus consulting an audiophonology center. | Clinical diagnosis of MDD (exact criteria unclear) | 80 | — | — | 28.8 | 2 |
Langguth26 | 2007 | Germany | Consecutive patients presenting to tinnitus clinic for tinnitus as their primary complaint | BDI ≥10 | 72 | 69.4 | 49.3 | 55.6 | 3 |
Meyer27 | 2014 | Switzerland | Chronic tinnitus patients volunteering for EEG study | BDI | 24 | 54.2 | 39.8 | 50.0 | 4 |
Michikawa28 | 2010 | Japan | Patients who self-reported tinnitus in the past year in a community-based cross-sectional study | Self-report questiona | 243 | 44.2 | >65 | 33.7 | 2 |
Milhomem Rocha29 | 2015 | Brazil | Concomitant tinnitus and musical hallucinations | SCID | 16 | 12.5 | 61.4 | 68.8 | 3 |
Nondahl30 | 2011 | USA | Patients who self-reported tinnitus in the past year from the Beaver Dam Offspring Study, an epidemiologic cohort study of aging | CES-D ≥ 16 | 345 | 51.3 | 50.8 | 24.6 | 4 |
Ooms11 | 2011 | Belgium | Consecutive tinnitus patients seen at ENT clinic | BDI-II | 136 | 64.7 | 49.1 | 33.1 | 4 |
Robinson31 | 2008 | USA | Patients with self-reported tinnitus distress volunteering for cognitive-behavior therapy trial (exclusion criterion: inability to participate in group) | HRSD | 65 | 52 | 55 | 24.6 | 4 |
Salonen32 | 2007 | Finland | Subjects who responded to survey on hearing loss and reported tinnitus with or without annoyance | aBDI | 343 | 41.2 | 70–85 | 19.0 | 3 |
Seo33 | 2016 | Korea | Subjects who were part of KNHANES and reported experiencing tinnitus in the past year | Self-report questionb | 3949 | — | 48.3 | 18.2 | 2 |
Shargorodsky34 | 2010 | USA | Subjects who were part of NHANES and reported experiencing tinnitus in the past year. | WHO WMH-CIDI | 2265 | — | 20–39 | 7.9 | 4 |
Sireci35 | 2012 | Italy | Patients with tinnitus referred to audiology clinic | SCL 90-R | 191 | 58.1 | 48.6 | 33.0 | 4 |
Trevis36 | 2016 | Australia | Patients who self-identified as experiencing constant tinnitus for at least 3 mo | BDI-II | 26 | 58 | 40.3 | 42.3 | 4 |
Vtillmann37 | 2013 | Germany | Patients with chronic tinnitus responding to mailed questionnaires | HADS≥8 | 118 | 77.1 | 55.6 | 41.5 | 3 |
Zirke38 | 2013 | Germany | Patients with tinnitus for at least 3 mo admitted to tinnitus center | CIDI | 100 | 45 | 49.6 | 37.0 | 2 |
Abbreviations: aBDI, abbreviated Beck Depression Inventory; (0–4, no or minimal depression; 5–7, mild depression; 8–15, moderate depression; and ≥16, severe depression); BDI, Beck Depression Inventory; CES-D, Center for Epidemiologic Studies Depression Scale; CIDI, Composite International Diagnostic Interview (evaluated per criteria of the International Classification of Diseases, Tenth Revision and Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition); DASS, Depression, Anxiety and Stress Scale; DSM-III, Diagnostic and Statistical Manual of Mental Disorders, Third Edition; EEG, electroencephalogram; ENT, ear, nose, and throat; HADS, Hospital Anxiety and Depression Scale (unless otherwise stated, >10); HRSD, Hamilton Rating Scale for Depression; KNHANES, Korea National Health and Nutrition Examination Survey; MDD, major depressive disorder; NHANES, National Health and Nutrition Examination Survey; PHQ-9, Patient Health Questionnaire-9; RDC/TMD, Research Diagnostic Criteria for Temporomandibular Disorders; SCI, Structured Clinical Interview; SCL 90-R, Symptom Checklist-90 R; WHO WMH-CIDI, World Health Organization World Mental Health Composite International Diagnostic Interview.
Depression was evaluated with the question “Do you feel sad, depressed, or miserable?”
Depression was evaluated with the question “Have you experienced a depressed mood for 2 or more continuous weeks during the previous year?”